日本薬理学会年会要旨集
Online ISSN : 2435-4953
WCP2018 (The 18th World Congress of Basic and Clinical Pharmacology)
セッションID: WCP2018_PO2-7-21
会議情報

Poster session
Screening of sulfated polysaccharide and sugar-related compounds as the regulator of advanced glycation end-products uptake by macrophage
Takashi NishinakaTakuro KoboriYui YamazakiShinichi HamasakiAtsuhiro KitauraAtsuko NiwaShuji MoriMasahiro NishiboriHideo Takahashi
著者情報
会議録・要旨集 オープンアクセス

詳細
抄録

[Background]

Advanced glycation end-products (AGEs) which result from the prolonged exposure of proteins to sugars accumulate in the blood and tissues of diabetic patients. Accumulated evidence suggests that the AGEs are associated with both microvascular and macrovascular complications including retinopathy, nephropathy, neuropathy and cardiovascular disease in diabetic mellitus. Especially among AGEs, toxic AGEs derived from glyceraldehyde (AGE-2) and glycolaldehyde (AGE-3) have potent activity compared to other AGEs. Macrophages are capable of ingesting extracellular particles by receptor-mediated endocytosis. AGEs can interact with two types of cell surface receptors on macrophages. Scavenger receptors including type I and type II macrophage scavenger receptors, such as class B scavenger receptor (CD36), scavenger receptors-1 class A (SR-A, CD204), and lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1), are predominantly involved in AGE capture, removal, and degradation. These receptors contribute to the development of atherosclerosis. Recently, we have demonstrated that the SR-A is involved in the AGEs uptake by macrophage. Furthermore, we found that the fucoidan which is a complex sulfated polysaccharide and a SR-A antagonist suppresses the AGEs uptake. These results raise the possibility that the sulfated polysaccharide or sugar-related compounds are candidate for the treatment of atherosclerosis. In the present study, we screened the sulfated polysaccharide or sugar related compounds as the regulator of AGES uptake by macrophage.

[Methods]

AGEs were prepared from BSA incubated with D-glyceraldehyde or D-glycoaldehyde at 37°C and fluorescently labelled by using Alexa Fluor 488 C5 maleimide. The mouse macrophage cell line, RAW264.7 were grown in Dulbecco's Modified Eagle Medium (DMEM) containing 2 mM glutamine and 10% heat-inactivated fetal bovine serum (FBS) at 37°C and 5% CO2. The cells were concomitantly treated with fluorescently labelled-AGEs and each compound for 1 h, then the AGEs uptake was evaluated by the flow cytometric analysis.

著者関連情報
© 2018 The Authors(s)
前の記事 次の記事
feedback
Top